Description
Description
Round biconvex tablets coated with a white film coating with an extruded symbol in the form of two drop-shaped elements on one side. In a cross section, the core is white or almost white.
Indications
Symptomatic treatment of pain, cramping and discomfort in the abdomen, bloating (flatulence), motor bowel disorders with changes in stool frequency (diarrhea or constipation), dyspepsia, heartburn, belching, nausea, vomiting, organ-associated vomiting intestinal tract and biliary tract (non-erosive form of gastroesophageal reflux disease gallstone disease biliary tract dysfunction irritable bowel syndrome sphincter of Oddi dysfunction, postcholecystectomy cue syndrome).
Postoperative paralytic intestinal obstruction.
Contraindications
Hypersensitivity to the components that make up the drug.
Pregnancy.
Children under 12 years of age (for this dosage form).
Precautions While Using
The drug Trimedat ® forte should be used with caution during breastfeeding, as there is no evidence of its ability to pass into breast milk.
Use during pregnancy and lactation
In experimental studies, no data were found on teratogenicity and embryotoxicity of the drug. However, due to the lack of necessary clinical data, the use of the drug Trimedat ® forte during pregnancy is contraindicated.
It is not recommended to prescribe Trimedat ® forte during lactation, due to the lack of reliable clinical data confirming the safety of the drug during this period.
If you need to use the drug during lactation, you should stop breastfeeding.
Special instructions
To prevent recurrence of irritable bowel syndrome after a course of treatment during the period of remission, it is recommended to continue taking a dose of 300 mg per day for 12 weeks.
Influence on the ability to drive vehicles and control mechanisms:
The drug does not have a sedative effect, does not affect the speed of the psychomotor reaction and can be used in people of various professions, including those requiring increased attention and coordination of movements.
however Considering possible side effects that may affect these abilities (dizziness and others), care should be taken when driving and engaging in other potentially dangerous activities.
Composition
One tablet contains:
active ingredient:
trimebutine maleate – 300 mg
excipients: microcrystalline
microcrystalline
povidone (K 25) partially hydrolyzed,
macrogol-3350,
titanium dioxide E 171,
talc.
Dosage and Administration
Inside. Adults and children over 12 years of age, 1 tablet 2 times a day (with a break of 12 hours).
The course of treatment for abdominal pain associated with functional diseases of the digestive tract and biliary tract is 28 days.
Side effects of the
From the digestive system: dry mouth, unpleasant taste, diarrhea, dyspepsia, nausea, constipation.
From the nervous system: drowsiness, fatigue, dizziness, headache, anxiety.
Allergic reactions: skin rash.
Other: menstrual irregularities, painful enlargement of the mammary glands, urinary retention.
Drug interaction
Drug interaction of the drug Trimedat ® forte is not described.
Overdose
There have been no cases of overdose of the drug Trimedat ® forte.
Treatment: drug withdrawal, gastric lavage, administration of activated carbon, symptomatic therapy. There are no specific antidotes.
Storage Conditions
In original packaging at a temperature not exceeding 25 ° C.
Keep out of the reach and sight of children.
Expiration
2 years.
Terms leave through pharmacies
without prescription
The dosage form of
tablet
